Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Fibroblasts are a dynamic cell type that achieve selective differentiated states to mediate acute wound healing and long-term tissue remodeling with scarring. With myocardial infarction injury, cardiomyocytes are replaced by secreted extracellular matrix proteins produced by proliferating and differentiating fibroblasts. Here, we employed 3 different mouse lineage-tracing models and stage-specific gene profiling to phenotypically analyze and classify resident cardiac fibroblast dynamics during myocardial infarction injury and stable scar formation. Fibroblasts were activated and highly proliferative, reaching a maximum rate within 2 to 4 days after infarction injury, at which point they expanded 3.5-fold and were maintained long term. By 3 to 7 days, these cells differentiated into myofibroblasts that secreted abundant extracellular matrix proteins and expressed smooth muscle α-actin to structurally support the necrotic area. By 7 to 10 days, myofibroblasts lost proliferative ability and smooth muscle α-actin expression as the collagen-containing extracellular matrix and scar fully matured. However, these same lineage-traced initial fibroblasts persisted within the scar, achieving a new molecular and stable differentiated state referred to as a matrifibrocyte, which was also observed in the scars of human hearts. These cells express common and unique extracellular matrix and tendon genes that are more specialized to support the mature scar.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and resemble POSTN-expressing matrifibrocytes7.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We used an Ang II/PE infusion model to study cardiac fibrosis which has inherent limitations3,4,7,39”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Computational lineage analysis predicted that FAP expression marks a fibroblast trajectory that transitions into populations including POSTN + matrifibrocytes 32 and myofibroblasts.”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Deaths: Leading Causes for 2017.
Heron, M. P. (2019) · PubMed · Cited by 2,406
Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis
Joe, A. W. B., Yi, L., Natarajan, A., Le Grand, F., So, L., Wang, J., Rudnicki, M. A., & Rossi, F. M. V. (2010) · Nature Cell Biology · doi:10.1038/ncb2015 · Cited by 1,690
Revisiting Cardiac Cellular Composition
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’Antoni, M. L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307778 · Cited by 1,400
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,360
Murphy, M. M., Lawson, J. A., Mathew, S. J., Hutcheson, D. A., & Kardon, G. (2011) · Development · doi:10.1242/dev.064162 · Cited by 1,249
Darby, I. A., Skalli, O., & Gabbiani, G. (1990) · PubMed · Cited by 1,189
Kajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892 · cited 5×
“We previously showed that myofibroblasts in the heart can dedifferentiate and revert back to an “uninjured” state after a cardiac stress response resolves, such as with Ang II/PE agonist infusion and then its removal (23).”
BackgroundInfluentialSelf-citationBryant, S. J., & Anseth, K. S. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.1217 · Cited by 845
Research works printed but not linked: 1
- 28. Ubil E, et al. Mesenchymal-endothelial transition contributes to cardiac neovascularization. Nature. 2014;514(7524):585–590. doi: 10.1038/nature13839. · DOI · Paper page
Cited by
Items 501–600 of 638
Bioactive materials for clinical applications of soft tissue regeneration
(2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99998-4.00004-3 · Cited by 3
Jenkins, T. L., Venkataraman, S., Saleh, A. M., Calve, S., Pourdeyhimi, B., & Little, D. (2025) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1155/term/2184723 · Cited by 3
Molecular signatures bidirectionally link myocardial infarction and lung cancer
Nandi, D., Janardhanan, R., Hannenhalli, S. S., & Agrawal, P. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1576375 · Cited by 2
“For example, Fu et al. showed that post-MI, fibroblasts show higher cell differentiation and proliferation for long-term tissue remodeling and wound healing (40).”
Bian, X., Gao, H., Guo, C., Lin, N., Gan, L., & Chen, X. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13680 · Cited by 2
“MYOs expressed fibrillogenic proteins, such as periostin (Postn) and contractile proteins such as smooth muscle actin (48), along with collagen genes, including col1a1, col3a1 and Col5a2 (49), which can drive collagen deposition with scar‑ ring, with a significant increase in numbers on day 7…”
InfluentialXuân, N. T., Kubota, S., Takigawa, M., & Nishida, T. (2025) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.70051 · Cited by 2
“39 This report clarified that the fibroblasts termed activated fibroblasts, which had high F I G U R E 5 Western blot analysis of type I collagen, α-SMA, CCN2, and PU.1 productions in NIH3T3 cells simultaneously transfected with p CCN2 - HA and pFlag - Spi1 .”
Akins, K. A., Arkatkar, A., Flinn, M. A., Sandor, N., Purdy, A. L., Brusacoram, A., Swift, S. K., Buday, S. L., Choudhury, P., Cui, M., et al. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2025.101455 · Cited by 6
Wu, Z., Zou, X., Chen, C., Zhou, M., Yue, X., Guo, D., Gao, Y., Ma, C., Han, Q., Yang, D., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.04.003 · Cited by 4
Matrifibrocytes Redefine Cardiac Fibrosis: From Terminal Differentiation to Translational Modulation
Zhang, Z., & Zhu, H. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71174 · Cited by 4
Direct Cardiac Reprogramming ― Converting Cardiac Fibroblasts to Cardiomyocytes ―
Sadahiro, T. (2019) · Circulation Reports · doi:10.1253/circrep.cr-19-0104 · Cited by 2
Huang, Z., Kang, J., Chen, P., Deng, L.-F., Li, J., He, Y.-X., Liang, J., Huang, N. J., Luo, T., Lan, Q.-W., et al. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10563-x · Cited by 2
“Collagen plays an essential role in cell growth and development or healing and regeneration (Fu et al. 2018).”
Molecular Mechanisms of the Failing Heart: A Fatal Regression?
Katoh, M., Komuro, J., Inoue, S., Nakayama, Y., & Komuro, I. (2024) · Journal of Asian Pacific Society of Cardiology · doi:10.15420/japsc.2024.07 · Cited by 2
Jafari, N., Zolfi-Gol, A., Rabori, V. S., & Saberiyan, M. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.101970 · Cited by 2
Novel Molecules Targeting Metabolism and Mitochondrial Function in Cardiac Diseases
Bolívar, S., Vásquez-Trincado, C., Rodriguez, K. P. T., Acosta, L., Pérez, M. F., Saavedra-Castro, S., Castiblanco-Arroyave, S. C., Higuera, G. M., Ariza, L. A. D., Ortiz, H. R., et al. (2025) · Current Cardiology Reviews · doi:10.2174/011573403x372565250331190001 · Cited by 2
“The differentiation of CF to CMF is characterized by high expression of the protein α-SMA and excessive production of ECM proteins, as well as resistance to cell death, which results in their permanency in the injured heart, leading to maladaptive cardiac tissue re-modeling [38].”
Tadros, H. J. J., Turaga, D., Zhao, Y., Tsai, C.-R., Adachi, I., Li, X., & Martin, J. F. (2025) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.125.005192 · Cited by 3
Huang, C., Knighton, N. J., Timmins, L. H., & Sachse, F. B. (2020) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ab8af8 · Cited by 3
“For instance, in myocardial infarction, cells including fibroblasts deteriorate in the ischemic zone [23].”
BackgroundIntegrins in Cancer: Refocusing on the Tumor Microenvironment
Zeltz, C., Lü, N., Heljäsvaara, R., & Gullberg, D. (2022) · Biology of extracellular matrix · doi:10.1007/978-3-030-99708-3_11 · Cited by 4
Is disrupting cardiac fibrosis a rational strategy for treating heart disease?
Hara, A., & Tallquist, M. D. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00069-x · Cited by 2
EphrinB2 drives osteogenic fate of adult cardiac fibroblasts in a calcium influx dependent manner
Li, W., Su, S., Chen, J., Shen, Y., Ma, H., & Xiang, M. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00301.2022 · Cited by 2
Investigation of mesalazine as an antifibrotic drug following myocardial infarction in male mice
Künzel, S. R., Winter, L., Hoffmann, M., Kant, T. A., Thiel, J., Kronstein‐Wiedemann, R., Klapproth, E., Lorenz, K., El‐Armouche, A., & Kämmerer, S. (2023) · Physiological Reports · doi:10.14814/phy2.15809 · Cited by 2
“…et al., 2017) due to persistent TGF β secretion, increased mechanic stress and inflammation (Humeres & Frangogiannis, 2019) lead to progressive interstitial and perivascular fibrotic remodeling and ultimately heart failure (Fu et al., 2018; Rog-Zielinska et al., 2016; Talman & Ruskoaho, 2016).”
BackgroundTargeting metabolically activated fibroblasts in the failing heart
Frangogiannis, N. G. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00500-5 · Cited by 2
Toward the Development of Novel Therapy for Hypertrophic Cardiomyopathy
Matsuura, K. (2018) · International Heart Journal · doi:10.1536/ihj.18-466 · Cited by 2
Contreras, O., Soliman, H., Théret, M., Rossi, F. M. V., & Brandan, E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.05.895334 · Cited by 3
Li, C., Sun, J.-W., Liu, Q.-L., Dodlapati, S., Hao, M.-H., Wang, L., Li, Y., Li, R., Jiang, Z., Francis, J., et al. (2021) · bioRxiv · doi:10.1101/2021.03.03.433814 · Cited by 1
“Thus, Stat1 may contribute to the increased ECM protein production by cardiac fibroblasts and their resistance to apoptosis after MI (1).”
BackgroundMethodResultInfluentialSelf-citationIdentification of CD4 + Sub-population of Resident Cardiac Fibroblasts Linked to Myocardial FibrosisPreprint
Siamwala, J. H., Pagano, F. S., Dubielecka, P. M., Zhao, A., Chen, S., Granston, H., Sadayappan, S., Rounds, S., & Gilbert, R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.26.433023 · Cited by 2
“Results employing these models demonstrate that circulating bone marrow-derived cells, CD14 fibrocytes, smooth muscle cells, and endothelial cells transform into cardiac myofibroblasts through endothelial to mesenchymal transitioning, which may constitute a source of myofibroblasts and deposition of excess of extracel…”
Li, Y., Li, C., Liu, Q., Wang, L., Bao, A. X., Jung, J. P., Francis, J., Molkentin, J. D., & Fu, X. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.20.445043 · Cited by 2
“IHC staining was performed as previously described (3).”
BackgroundMethodInfluentialSelf-citationp53 at the Intersection of Cardiac Fibroblast Proliferation and Activation: Answers and Questions
Ghigo, A., & Ameri, P. (2023) · Circulation Research · doi:10.1161/circresaha.123.323209 · Cited by 3
Targeting RUNX1 in Macrophages Facilitates Cardiac RecoveryPreprint
Amrute, J., Zhu, A., Pai, Y.-L., Hector-Greene, M., An, Y., Kim, K. R., Sheth, M. U., Padmanabhan, A., Lee, C. Y., Yamawaki, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.25.665779 · Cited by 8
Baddour, T., Ninh, V. K., Gorashi, R. M., Peña, R., King, K. R., & Aguado, B. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.20.671175 · Cited by 2
“Additionally, myofibroblast lineage tracing in a myocardial infarct mouse model revealed a COMP positive matrifibrocyte that persists in scar tissue 41 .”
Sadaf, S., Vasamsetti, S. B., Jamal, I., Johny, E., Kubra, K., Haque, S., Mannan, A. A. S. R., Razani, B., Chaparala, S., Okawa, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.10.681697 · Cited by 5
Yudintceva, N. M., Kolesnichenko, Y. V., Shatrova, A. N., Aksenov, N., Yartseva, N. M., Shevtsov, M. A., Fedorov, V., Георгиевич, Х. М., Ziganshin, R., & Михайлова, Н. А. (2024) · Biomedicines · doi:10.3390/biomedicines12102295 · Cited by 2
“The mechanism of hypertrophic scar formation is associated with abnormal proliferation and transformation of fibroblasts in response to damage [57].”
BackgroundKumari, K., Verma, K., Sahu, M., Dwivedi, J., Paliwal, S., & Sharma, S. K. (2025) · Vascular Pharmacology · doi:10.1016/j.vph.2025.107473 · Cited by 1
Chen, B.-X., Hu, H., Gong, J., Xi, X.-Y., Ma, Y., Yang, Y., Yang, M.-F., & Li, Y. (2025) · BMC Medical Imaging · doi:10.1186/s12880-025-01592-6 · Cited by 2
“Disease associated fibroblast marked by cell surface expression of FAP which divided into distinct myofibro-blasts and pro-fibrotic fibroblast populations [29].”
Advances in fibroblast-based cardiac reprogramming in the treatment of heart disease
Jin, Y., Liu, Y., Ge, A., Yang, Y. P., Wan, Y., Li, C., & Zhang, C. (2025) · Inflammation Research · doi:10.1007/s00011-025-02079-4 · Cited by 3
“Following M), CFs progress through four cellular states: quiescent fibroblasts (qFBs), activated fibroblasts (aFBs), myofibroblasts (MyoFBs), and stromal fibroblasts (sFBs) [ 88 ].”
Dragomiretskaya, N. A., Volchkov, I. I., Белов, А. В., Gontsova, L. A., Vetluzhskaya, M. V., & Podzolkov, V. I. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6397 · Cited by 1
Wang, T., Hu, Y., Guo, W., Li, H., Wang, M., Chen, B., Bao, H., Gao, M., Li, X., Chen, Q., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.11.020 · Cited by 1
“S2C) 5,6 .”
Ciortan, L., Gan, A., Cecoltan, S., Serbanescu, M. A., Mihaila, A. C., Macarie, R. D., Tucureanu, M. M., Naie, M. L., Preda, M. B., Cosman, B.-P., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13112829 · Cited by 1
“These transitions include a proinflammatory state, a matrix-synthetic phenotype, and ultimately, they acquire a quiescent phenotype during the maturation phase of healing [36].”
Single cell transcriptomic landscape of adult and pediatric non-ischemic cardiomyopathy
Tadros, H. J. J., Turaga, D., Hope, K. D., Spinner, J. A., Adachi, I., Li, X., & Martin, J. F. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.12.002 · Cited by 1
Wang, Q., Huang, W., Xia, D., Wang, F., & Nair, S. (2026) · Human Mutation · doi:10.1155/humu/4574795 · Cited by 1
“TGF-β 1 promotes the transformation of cardiac fi broblasts into myo fi broblasts; α -SMA, an indicator of mature myo fi broblasts, is signi fi - cantly upregulated in the infarct border zone [36].”
Leptin Receptor Fibroblasts Are Preferential Contributors to Cardiac Fibrosis
Larcher, V., Fischer, A., Zhang, L., Almolla, O., Chiesa, M., Andriani, F., Wernet, C., Serio, S., Tombor, L., Peruzzo, S., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.327701 · Cited by 2
Urbanowicz, T. K., & Filipiak, K. J. (2026) · Cells · doi:10.3390/cells15141308 · Cited by 1
MMP12 induces fibrogenic macrophage differentiation to drive granuloma-associated cardiac fibrosis
Mazic, M., Lim, C. X., Saha, P., Jammal, T. E., Sango, R., Ghazi, T., Jahić, A., Ettel, P., Jager, J., Asimaki, A., et al. (2026) · American Journal of Respiratory and Critical Care Medicine · doi:10.1093/ajrccm/aamag354 · Cited by 2
Cardiomyocyte-expressed TGFβ programs early heart maturation and adult myocyte identity
Minerath, R. A., Kasam, R. K., Swoboda, C. O., Prasad, V., Grimes, K. M., Blair, N. S., Khalil, H., Alfieri, C. M., Eads, L., Saviola, A. J., et al. (2026) · Nature Cardiovascular Research · doi:10.1038/s44161-026-00892-6 · Cited by 6
Self-citationBarefield, D. Y., & Garbincius, J. F. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.011097 · Cited by 1
The myofibroblast: Role in fibrosis development
Gabbiani, G., Coen, M., & Zampieri, F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90546-6.00010-1 · Cited by 1
Inter- and Intracellular Signaling Pathways
Dobreva, G. D., & Heineke, J. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-44087-8_15 · Cited by 1
Mohr, T., Schiffer, M., Ramanujam, D. P., Carls, E., Zgierski-Johnston, C. M., Kok, T., Niemann, P., Geisen, C., Köhl, P., Engelhardt, S. H., et al. (2025) · The Journal of Physiology · doi:10.1113/jp288020 · Cited by 5
“MMLV complexes were injected 3 days after CI, a time at which resident FB are activated and known to peak in the proliferation rate, which is a prerequisite for successful MMLV transduction (Fu et al., 2018; Ramanujam et al., 2016).”
InfluentialThe cardiac stem cell niche during aging
Clayton, Z. E., Hume, R. D., Selvakumar, D., & Chong, J. J. H. (2020) · Advances in stem cells and their niches · doi:10.1016/bs.asn.2020.05.004 · Cited by 1
Wang, X., Song, T., Sun, Y., Men, L., Gu, Y., Zhang, S., & Chen, X. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00713 · Cited by 1
Local Preirradiation of Infarcted Cardiac Tissue Substantially Enhances Cell Engraftment
Abizanda, G., López-Muneta, L., Linares, J., Ramos, L. I., Churio, A. B., Bobadilla, M., Iglesias, E., Coppiello, G., Ripalda‐Cemboráin, P., Aranguren, X. L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179126 · Cited by 1
“On the other hand, AMI causes a continuous cardiac remodeling process and different cell populations, including inflammatory cells or cardiac fibroblasts at different activation states, are present or enriched on a given day after injury [18].”
BackgroundCardiac Tissue Engineering: A Pathway for Repair
Hortensius, R. A., Lin, W., Fontenot, J. F., Ogle, B. M., & Jung, J. P. (2024) · Springer eBooks · doi:10.1007/978-3-031-71067-4_15 · Cited by 1
Cardiac fibroblast GSK-3α mediates adverse myocardial fibrosis via IL-11 and ERK pathwayPreprint
Umbarkar, P., Tousif, S., Singh, A. P., Anderson, J. C., Zhang, Q., & Lal, H. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.02.429435 · Cited by 1
Liu, C., Zhou, D., Zhang, Q., Wei, H.-Y., Lu, Y., Li, B., Zhan, H., Cheng, J., Wang, C., Yang, Y., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2009086/v1 · Cited by 1
Schiffer, M., Wagner, K., Carls, E., Nicke, J., Hesse, M., Fratila, R. M., Hildebrand, S., Eberbeck, D., Mohammadi, M. M., de la Fuente, J. M., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4786591 · Cited by 1
RNA Therapeutics for In Vivo CAR-Macrophage: Advancing Cardiac Immunotherapy
Ben‐Aicha, S., Shmool, T. A., & Emanueli, C. (2025) · Circulation Research · doi:10.1161/circresaha.125.327128 · Cited by 1
Yang, C., Wu, J., Zhu, S., Yang, X., Yang, Y., Tao, Y., Zhou, B., Tang, C., & Zhao, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-2928769/v1 · Cited by 2
An interaction between Gβγ and RNA polymerase II regulates transcription in cardiac fibroblastsPreprint
Khan, S. M., Martin, R. D., Gora, S., Bouazza, C., Jones-Tabah, J., Zhang, A., MacKinnon, S., Trieu, P., Clarke, P. B. S., Tanny, J. C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/415935 · Cited by 1
Liu, Q., Mukhopadhyay, S., Rodriguez, M. X. B., Fu, X., Sahu, S. P., Burk, D. H., & Gartia, M. R. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2001.08395
“Heart tissue sections were processed and obtained following protocols published elsewhere [15].”
MethodSelf-citationBlythe, N. M. (2019) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Stem Cell Therapy to Improve Acute Myocardial Infarction Remodeling
Gorecka, J., & Dardik, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-56954-9_14 · Cited by 1
Molecular Basis of Heart Failure
Diwan, A., & Hill, J. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-60987-6.00001-6
Fibroblast State Reversal By MBNL1-Dependent Transcriptome Modification Regulates Cardiac RepairPreprint
Bugg, D., Bretherton, R. C., Beach, K. E., Reese, A., Gunaje, J., Flint, G., Deforest, C., Stempien-Otero, A., & Davis, J. M. (2021) · bioRxiv · doi:10.1101/2021.01.26.428279
“Often dedifferentiation is associated with heightened cellular proliferation (Daseke et al., 2020; Fu et al., 2018; Mouton et al., 2019b), and given MBNL1 overexpression inhibited cardiac”
BackgroundInfluentialStasi, A., Franzin, R., Netti, G. S., Ranieri, E., Gesualdo, L., Stallone, G., & Castellano, G. (2021) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-62129-2_7
Pericytes in Myocardial Diseases
Alex, L., Tuleta, I., & Frangogiannis, N. G. (2021) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-62129-2_10
Su, W., Fang, R., Li, Y., Li, L., Zhang, J., Lv, X., Yang, N., Wang, Q., Zhang, G., Li, X., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1023805/v1
Stüdemann, T., & Weinberger, F. (2022) · Springer eBooks · doi:10.1007/978-3-030-86140-7_7
Rehman, A. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8693
Dong, Y., Wang, B., Du, M., Zhu, B., Cui, K., Chan, S., Cowan, D. B., Bhattacharjee, S., Shan, D., Wong, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.09.503324
Interleukin-11 signaling is a global molecular switch between regeneration and scarring in zebrafish
Allanki, S. (2022) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.70677
Maurer, W. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9728
Re-engineering cardio-oncology testing using biomimetic heart slice cultures.
Miller, J. P. (2022) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/4025
Humeres, C. D., Venugopal, H., & Frangogiannis, N. G. (2023) · Cardiac and vascular biology · doi:10.1007/978-3-031-23965-6_4 · Cited by 1
Primary myocardial fibrosis — a distinct entity characterized by heterogeneous histology
Pakanen, L., Appel, H., Ahtikoski, A. M., Holm, P. H., Kreus, M., Olsen, K. B., Banner, J., Winkel, B. G., Huikuri, H. V., Kaarteenaho, R. L., et al. (2023) · Cardiovascular Pathology · doi:10.1016/j.carpath.2023.107573 · Cited by 2
Schiffer, M., Wagner, K., Carls, E., Nicke, J., Hesse, M., Fratila, R. M., Hildebrand, S., Pfeifer, A., Eberbeck, D., Mohammadi, M. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.16.580672
“Thus, cardiac myofibroblasts resist the adverse local conditions in ischemic lesions, stabilize these against rupture and play a key role in scar formation (28, 29).”
BackgroundWang, Z., Yang, M., Li, S., Chi, H., Wang, J., & Xiao, C. (2024) · PubMed Central · doi:10.12122/j.issn.1673-4254.2024.04.07 · Cited by 1
Butler, K. V., Ahmed, S., Jablonski, J., & Hookway, T. A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.13.593960
“Myofibroblasts are derived from a population of resident fibroblasts in the heart, approximately 80% of which are epicardial in origin[2], [3], highlighting the importance of the epicardium in heart repair.”
BackgroundSingle-Cell Revelations in Tricuspid Valve Remodeling
Jiang, X., & Huang, J. (2025) · JACC Asia · doi:10.1016/j.jacasi.2025.02.009
Cardiomyocyte Proliferation and Cardiac Cell Therapy
Li, F., & Zhu, W. (2025) · Springer eBooks · doi:10.1007/978-3-031-81743-4_9
Aguado‐Alvaro, L. P., Garitano, N., Esser‐Skala, W., Sayers, J., del Valle, C., Alameda, D., Mendieta-Esteban, J., Calleja-Cervantes, M. E., Goñi‐Salaverri, A., Zazpe, J., et al. (2025) · Qeios · doi:10.32388/2cc4zm
Zhang, L. T., Power, A., Kang, N., & Ward, M. (2025) · Physiological Reports · doi:10.14814/phy2.70509
“Notably, fibroblasts further elongated and proliferated post-infarction, indicating their fibrotic activation (Fu et al., 2018).”
Tadros, H. J. J., Turaga, D., & Martin, J. F. (2025) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-025-01115-0
“A terminal cell population identified were the MFCs which express chondrogenic and osteogenic ECM gene signatures and lack contractile functions seen in MYOs, theorized to participate in cardiac remodeling [ 16, 17].”
Natarajan, N., Xiao, H., Haque, S., Cundiff, M. D., Hara, M., Sriram, V., Das, J., & Dutta, P. (2025) · medRxiv · doi:10.1101/2025.08.18.25333841 · Cited by 3
Larcher, V., Fischer, A., Zhang, L., Almolla, O., Chiesa, M., Andriani, F., Wernet, C., Serio, S., Tombor, L. S., Peruzzo, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.14.682477
Yang, B., Chen, J., Mi, Q., Huo, J., Gao, N., Lin, X., Molkentin, J. D., & Meng, Q. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.04.692460
Self-citationYang, S., Pei, L., Huang, Z., Zhong, Y., Li, J., Hong, Y., Long, H., Chen, X., Zhou, C., Zheng, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734467
Liu, Z., Klose, K., Neuber, S., Jiang, M., Gossen, M., & Stamm, C. (2020) · Figshare · doi:10.6084/m9.figshare.13257489
Du, L., Sun, X., Gong, H., Wang, T., Jiang, L., Huang, C., Xu, X., Li, Z., Xu, H., Ma, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22613107
Yang, S., Pei, L., Huang, Z., Zhong, Y., Li, J., Hong, Y., Long, H., Chen, X., Zhou, C., Zheng, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734458
Yang, S., Pei, L., Huang, Z., Zhong, Y., Li, J., Hong, Y., 龙会宝, Chen, X., Zhou, C., Zheng, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734461
Ke, D., Cao, M., Ni, J., Yuan, Y., Deng, J., Chen, S., Dai, X., & Zhou, H. (2024) · Figshare · doi:10.6084/m9.figshare.26732926
Liu, Z., Klose, K., Neuber, S., Jiang, M., Gossen, M., & Stamm, C. (2020) · Figshare · doi:10.6084/m9.figshare.13257486
Yang, S., Pei, L., Huang, Z., Zhong, Y., Li, J., Hong, Y., Long, H., Chen, X., Zhou, C., Zheng, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734464
Iwai, S., Yajima, S., Yoshioka, D., Kawamura, T., Kawamura, A., Misumi, Y., Saito, S., & Miyagawa, S. (2025) · Annals of Thoracic Surgery Short Reports · doi:10.1016/j.atssr.2025.11.029
LI, Y., Zhang, X., Ghimire, K., Khatri, N., Wang, L., Liu, Q., Shiri, M., Shakoori, R., Upadhayaya, S., Li, B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.12.699153
Self-citationActivation of developmental transcription factors using RNA technology promotes heart repairPreprint
Leonard, R. J., Sweat, M., Eliason, S. L., Kutschke, W. J., & Amendt, B. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.16.700013
“Infarct zone expression of these factors was similar at 1 and 3 WPI, in WT and PMIS-C, indicating that inhibiting miR-200c does not affect the process associated with activated fibroblasts and remodeling of the myocardium following adult injury 63 .”
The Hippo pathway in cardiac fibrosis: mechanisms and therapeutic prospects
Qiu, Y., Hu, S., Li, H., Ren, J., Liao, M., Huo, J., Luo, Z., & Lu, L. (2026) · Human Cell · doi:10.1007/s13577-026-01352-w · Cited by 1
“Myofibroblasts possess an enhanced capacity to secrete collagen, which can result in abnormal deposition of the extracellular matrix (ECM) and the formation of extensive fibrotic scars in the damaged regions of the heart [11].”
Metadata
- Authors
- Fu, X., Khalil, H., Kanisicak, O., Boyer, J. G., Vagnozzi, R. J., Maliken, B. D., Sargent, M. A., Prasad, V., Valiente-Alandi, I., Blaxall, B. C., & Molkentin, J. D.
- Affiliations
- Louisiana State University (US)
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Molkentin, Jeffery D.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2018-04-16
- Volume
- 128
- Issue
- 5
- Pages
- 2127-2143
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5957472
- OpenAlex
- W2800350399
- Cited by
- 636
- References
- 54
- Citations by year
- 2026: 58 · 2025: 81 · 2024: 71 · 2023: 93 · 2022: 87 · 2021: 86 · 2020: 90 · 2019: 52 · 2018: 17
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Civil War Book Review (submittedVersion)
- Funders
- National Institutes of Health (R01 HL142217)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Keywords
- cardiac fibroblasts, myocardial infarction, scar formation, myofibroblasts, fibroblast differentiation, lineage tracing, extracellular matrix, smooth muscle actin, collagen, cardiac remodeling, wound healing
- MeSH terms
- Animals, Cell Differentiation, Cicatrix, Extracellular Matrix, Female, Humans, Male, Myocardial Infarction, Myocardium, Extracellular Matrix Proteins, Myoblasts, Cardiac, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.